Polymer Synthesis Laboratory, KAUST Catalysis Center, Physical Sciences and Engineering Division, King Abdullah University of Science and Technology (KAUST), Thuwal 23955, Saudi Arabia.
Department of Chemistry, Institute for Polymer Research, University of Waterloo, 200 University Avenue West, Waterloo, Ontario N2L 3G1, Canada.
Biomacromolecules. 2022 Jun 13;23(6):2441-2458. doi: 10.1021/acs.biomac.2c00202. Epub 2022 May 19.
This paper reports novel hybrid arborescent polypeptides based on poly(γ-benzyl l-glutamate)--poly(γ--butyl l-glutamate)--polysarcosine [P(BG--Glu(OBu))--PSar]. The synthesis is launched by ring-opening polymerization (ROP) of -carboxyanhydride of γ-benzyl l-glutamate (BG-NCA) and γ--butyl l-glutamate (Glu(OBu)-NCA) to synthesize a random copolymer P(BG--Glu(OBu)) serving as a precursor for the arborescent system, followed by deprotection of the -butyl (Bu) groups to afford free COOH moieties serving as coupling sites. Two copolymerization reactions were carried out to afford the side chains. One type of side chain was a random copolymer P(BG--Glu(OBu)), while the other type was a triblock copolymer PGlu(OBu)--PBG--PGlu(OBu). The peptide coupling reactions were conducted between the COOH moieties on the precursor and the terminus amine on the chain end of the P(BG--Glu(OBu)) random copolymer or the PGlu(OBu)--PBG--PGlu(OBu) triblock copolymer to obtain G0 polymers. Afterward, hydrolyzing the Bu moieties of the G0 substrates yielded randomly functionalized G0 and end-functionalized G0. Randomly functionalized G0 was used as a substrate for the next generation G1 (randomly functionalized and end-functionalized G1 after deprotection) or coated with polysarcosine (PSar) to gain G0--PSar. The G0 substrate prepared with the triblock copolymer PGlu(OBu)--PBG--PGlu(OBu) was only grafted with PSar after deprotection, resulting in G0--PSar. Depending on the functionality mode of the G1 substrate, the PSar coating yielded two different graft polymers, G1--PSar and G1--PSar, for randomly functionalized and end-functionalized G1, respectively. The PSar hydrophilic shell was decorated with the sequence of (arginine, glycine, and aspartic acid) tripeptides (RGD) as a targeting ligand to improve the potentiality of the arborescent unimolecular micelles as drug carriers. Preparative size exclusion chromatography (SEC) was used to fractionate these complex macromolecular architectures. Nuclear magnetic resonance (NMR), Fourier-transform infrared (FTIR), Raman spectroscopy, and SEC were used for molecular characterization of all intermediate and final products and dynamic light scattering (DLS), transmission electron microscopy (TEM), and atomic force microscopy (AFM) for micellar characterization. A comparison between randomly grafted () and end-grafted () unimolecular micelles demonstrates that the former has an undefined core-shell structure, unlike its end-grafted analog. In addition, this study has proved that decoration of the shell with RGD contributed to avoiding micelle aggregation but limited chemotherapy agent encapsulation. However, more than their naked analog, the sustained release was noticeable in decorated micelles. Doxorubicin was utilized as a chemotherapy model, and loading was achieved successfully by physical entrapment.
本文报道了基于聚(γ-苄基 L-谷氨酸)-聚(γ-正丁基 L-谷氨酸)-聚肌氨酸[P(BG-Glu(OBu))-PSar]的新型杂树枝状多肽。该合成通过 - 羧基酸酐的开环聚合(ROP)合成,- 羧基酸酐的 γ-苄基 L-谷氨酸(BG-NCA)和 γ-正丁基 L-谷氨酸(Glu(OBu)-NCA),合成作为树枝状系统前体的无规共聚物 P(BG-Glu(OBu)),然后脱保护 - 丁基(Bu)基团以提供用作偶联位点的游离 COOH 部分。进行了两种共聚反应以提供侧链。一种侧链是无规共聚物 P(BG-Glu(OBu)),另一种是三嵌段共聚物 PGlu(OBu)-PBG-PGlu(OBu)。在 P(BG-Glu(OBu))无规共聚物或 PGlu(OBu)-PBG-PGlu(OBu)三嵌段共聚物的链端胺和前体上的 COOH 部分之间进行肽偶联反应,以获得 G0 聚合物。之后,水解 G0 底物上的 Bu 部分,得到随机功能化的 G0 和端功能化的 G0。随机功能化的 G0 用作下一个 G1(脱保护后为随机功能化和端功能化的 G1)的底物,或用聚肌氨酸(PSar)涂覆以获得 G0-PSar。用三嵌段共聚物 PGlu(OBu)-PBG-PGlu(OBu)制备的 G0 底物仅在脱保护后接枝 PSar,得到 G0-PSar。根据 G1 底物的功能模式,PSar 涂覆分别为随机功能化和端功能化的 G1 生成两种不同的接枝聚合物,G1-PSar 和 G1-PSar。PSar 亲水壳层用精氨酸、甘氨酸和天冬氨酸三肽(RGD)序列修饰作为靶向配体,以提高树枝状单分子胶束作为药物载体的潜力。制备性尺寸排阻色谱(SEC)用于分离这些复杂的大分子结构。核磁共振(NMR)、傅里叶变换红外(FTIR)、拉曼光谱和 SEC 用于所有中间和最终产物的分子表征,动态光散射(DLS)、透射电子显微镜(TEM)和原子力显微镜(AFM)用于胶束表征。随机接枝()和端接枝()单分子胶束的比较表明,前者具有未定义的核壳结构,与端接枝类似物不同。此外,本研究证明了壳层用 RGD 修饰有助于避免胶束聚集,但限制了化疗药物的包封。然而,与裸类似物相比,在修饰的胶束中可以观察到明显的持续释放。阿霉素被用作化疗模型,并通过物理包埋成功实现了负载。